221 related articles for article (PubMed ID: 2138228)
21. Interferon receptors on the surface of interferon-sensitive and interferon-resistant urothelial carcinomas.
Grups JW; Bange FC
Urol Res; 1990; 18(2):119-22. PubMed ID: 2140214
[TBL] [Abstract][Full Text] [Related]
22. Induction of growth suppression and modification of gene expression in multi-drug-resistant human glioblastoma multiforme cells by recombinant human fibroblast and immune interferon.
Moulton TA; Jiang H; Guarini L; Fetell MR; Fisher PB
Int J Cancer; 1992 May; 51(3):373-8. PubMed ID: 1317362
[TBL] [Abstract][Full Text] [Related]
23. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
[TBL] [Abstract][Full Text] [Related]
24. Antiproliferative effects of interferons against human bladder carcinoma cell lines in vitro.
Grups JW; Frohmüller HG
Urol Int; 1988; 43(5):265-8. PubMed ID: 2462294
[TBL] [Abstract][Full Text] [Related]
25. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
Sharp NA; Luscombe MJ; Clemens MJ
Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
[TBL] [Abstract][Full Text] [Related]
26. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
Kost ER; Mutch DG; Herzog TJ
Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of c-myc expression by tumor necrosis factor-alpha in combination with transforming growth factor-beta or interferon-gamma with concomitant inhibition of proliferation in human cell lines.
Hori M; Kamijo R; Takeda K; Nagumo M
J Interferon Res; 1994 Apr; 14(2):49-55. PubMed ID: 8077765
[TBL] [Abstract][Full Text] [Related]
28. Suppression of metastasis-associated S100A4 gene expression by gamma-interferon in human colon adenocarcinoma cells.
Takenaga K
Br J Cancer; 1999 Apr; 80(1-2):127-32. PubMed ID: 10389988
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
[TBL] [Abstract][Full Text] [Related]
30. Establishment of new interferon-gamma-resistant mutant cells with dominant phenotypes.
Ohta T; Ando O; Kurimoto M
J Interferon Cytokine Res; 1995 Feb; 15(2):153-60. PubMed ID: 8590319
[TBL] [Abstract][Full Text] [Related]
31. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA.
Hubbell HR; Liu RS; Maxwell BL
Cancer Res; 1984 Aug; 44(8):3252-7. PubMed ID: 6204744
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of the human IFN-gamma receptor expression in Raji and IM9 lymphoblastoid cells versus THP-1 monocytic cells by IFN-gamma and phorbol myristate acetate.
Mao C; Merlin G; Aguet M
J Immunol; 1990 Jun; 144(12):4688-96. PubMed ID: 2141042
[TBL] [Abstract][Full Text] [Related]
33. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
[TBL] [Abstract][Full Text] [Related]
34. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
[TBL] [Abstract][Full Text] [Related]
35. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells.
Izumi Y; Taniuchi Y; Tsuji T; Smith CW; Nakamori S; Fidler IJ; Irimura T
Exp Cell Res; 1995 Jan; 216(1):215-21. PubMed ID: 7529188
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
37. Analysis of interferon-gamma resistant mutants that are possibly defective in their signaling mechanism.
Feng GS; Dai W; Gupta SL; Werner-Felmayer G; Wachter H; Takikawa O; Taylor MW
Mol Gen Genet; 1991 Nov; 230(1-2):91-6. PubMed ID: 1720865
[TBL] [Abstract][Full Text] [Related]
38. Antisense manganese superoxide dismutase mRNA inhibits the antiviral action of interferon-gamma and interferon-alpha.
Raineri I; Huang TT; Epstein CJ; Epstein LB
J Interferon Cytokine Res; 1996 Jan; 16(1):61-8. PubMed ID: 8640453
[TBL] [Abstract][Full Text] [Related]
39. The effect of alpha and gamma-interferon on proliferation and production of IgE and beta 2-microglobulin in the human myeloma cell line U-266 and in an alpha-interferon resistant U-266 subline.
Brenning G; Jernberg H; Gidlund M; Sjöberg O; Nilsson K
Scand J Haematol; 1986 Oct; 37(4):280-8. PubMed ID: 3097807
[TBL] [Abstract][Full Text] [Related]
40. Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2 renal-carcinoma cells.
Gohji K; Fidler IJ; Tsan R; Radinsky R; von Eschenbach AC; Tsuruo T; Nakajima M
Int J Cancer; 1994 Aug; 58(3):380-4. PubMed ID: 8050821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
